The ability to analyze gene expression at the single-cell level — known as single-cell RNA sequencing (scRNA-seq) — has ...

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...

Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company's sequencing ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Q1 results, resolving litigation, but faces trade and NIH policy challenges. Click for my look at TXG stock prospects.

The high-end cellomics market size has grown robustly in recent times, scaling from $2.90 billion in 2024 to $3.15 billion in 2025, marking a compound annual growth rate CAGR of 8.6%. The surge in ...

Launched with 300 million cells and growing, Arc’s collection of computation-ready, single-cell measurements is getting a boost from 10x and Ultima technologies ...

To support researchers using 10x Genomics’ Chromium Universal Gene Expression assays, both companies have collaborated to make datasets for two single-cell samples (Jurkat & 293T) available online.

New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.